| CAS No. | 389799-97-7 |
| Molecular Formula | C5H14BNO2 |
| Molecular Weight | 130.98 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Structurally, Ixazomib Impurity 79 (C5H14BNO2) contains an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage. The molecule exhibits a degree of unsaturation (DBE) of -0.5, corresponding to approximately 0 ring(s) or double-bond equivalent(s). With a molecular weight of 130.98 g/mol, it falls into the low-molecular-weight range. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
CATO supplies Ixazomib Impurity 79 (CAS 389799-97-7), a pharmacopoeial impurity reference standard (molecular formula C5H14BNO2, MW 130.98 g/mol) used for the identification and quantification of trace impurities in APIs.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Ixazomib Impurity 79 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
| Molecular Formula | C5H14BNO2 |
| Molecular Weight | 130.98 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in methanol, acetonitrile, DMSO, water (slightly soluble) |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | -0.5 |
| CAS Registry Year (est.) | 2025 |
| Nitrogen Atoms | 1 |